AI model for predicting rectal surgery difficulty
Part of Cancer, Digestive system clinical trials.
This trial is testing a computer model that helps doctors predict how difficult rectal cancer surgery will be, so they can choose the best approach. The study aims to improve surgical planning and outcomes for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of rectal adenocarcinoma (a type of rectal cancer).
- Your tumor is located between 1 and 7 cm from the anal verge (the opening of the rectum).
- Your cancer is at a stage where it has not spread to distant organs (M0) and is limited to T1-T3.
- You are healthy enough to undergo laparoscopic (minimally invasive) surgery.
- You do not require lateral lymph node dissection (removal of lymph nodes) as part of your surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an artificial-intelligence support tool that helps surgeons make decisions during surgery for rectal cancer. If you qualify, the tool may be used alongside the surgical team to support safer, more effective care.
This study compares how an artificial intelligence system and a team of cancer doctors recommend treatment for rectal cancer. By understanding how well they agree, researchers hope to improve cancer treatment planning.
This study tests an AI system that helps identify cancer or polyp findings during rectal surgery or assessment, using real-time information. It may help surgeons classify tissue more accurately while you are already getting treatment.
This study uses an AI computer program to read special MRI images and predict how well treatment (given before surgery) will work for people with locally advanced rectal cancer. It may help doctors better plan who benefits most from neoadjuvant therapy (treatment before surgery).
This study is testing whether an artificial intelligence system can find very small amounts of leftover cancer (minimal residual disease) after treatment for rectal or esophageal cancer. If successful, this could help doctors detect a relapse earlier than current methods.
This trial tests an AI-based platform to help plan the best surgery for people with colon or rectal cancer. It aims to improve decision-making by both doctors and patients.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.